- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01438398
Efficacy & Safety of Submucosal Endoscopic Myotomy With Mucosal Flap (SEMF) in the Treatment of Patients With Achalasia
A Prospective, Single Center, Proof of Concept Pilot Study of the Efficacy and Safety of Submucosal Endoscopic Myotomy With Mucosal Flap (SEMF) Technique in the Treatment of Patients With Achalasia
The purpose of this study is to learn about the safety and usefulness of a procedure called endoscopic submucosal myotomy, which is a new technique in the treatment of achalasia. Achalasia is a disorder involving the lack of smooth muscle relaxation and sustained high pressure in the sphincter (muscle) of the lower esophagus. This may result in symptoms such as difficulty in swallowing, chest pain, regurgitation of food and eventually, weight loss.
For more than a decade, a laparoscopic surgical procedure known as Heller myotomy has been the primary treatment for achalasia in patients with low surgical risk. In Heller myotomy, the surgeon makes three to four small abdominal incisions, inserts tube-like instruments through them, and once inside, the junction between the esophagus and stomach is found, a lengthwise incision is made on the muscular ring surrounding the lower esophageal sphincter which weakens the muscle and the lower esophageal sphincter or muscle (LES) is then able to open more easily. However, there is an emerging field known as natural orifice (opening) transluminal (through the lumen) endoscopic surgery (NOTES). This approach involves passing an endoscope - a thin tube with a built-in camera, light and minuscule tools through the natural opening in the body, like the mouth in order to perform less invasive surgery without any external wounds or scars. The procedure is done using the Submucosal Endoscopy with Mucosal Flap (SEMF) technique which involves passing an endoscope through the mouth into the esophagus, where a small incision is made on the lining of the esophagus, known as the mucosa. A balloon is then inserted and dilated in the submucosa - the layer between the inner lining of the esophagus and the outer wall consisting of the muscle of the esophagus. Dilation of the balloon in the submucosa creates a tunnel that allows insertion of the endoscope and access to the muscle of the lower esophageal sphincter (LES). A long incision is then carefully made on the posterior portion of the muscular ring that forms the LES. The incision divides the muscle fibers of the LES, which weakens the muscle, allowing for the easier passage of food while preserving some valve function to prevent reflux of acid from the stomach into the esophagus.
The expected duration of participation is up to 10 years from the time study participants undergo the endoscopic surgical procedure.
Study Overview
Status
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Mineola, New York, United States, 11501
- Winthrop University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients 18 years or older, male or female, belonging to any race or ethnic origin
- Patients with manometric positive diagnosis of achalasia, with corresponding symptoms of dysphagia, regurgitation of food or chest pain
- Patients who are willing and competent to sign Informed Consent and to comply with study related visits and procedures
Exclusion Criteria:
- Patients who are below 18 years of age
- Presence of coagulopathy
- Pregnancy
- Patients who, in the investigator's opinion, are medically unstable, are unable to give informed consent, or whose risks outweigh the benefits of participating in the study
- Vulnerable subjects: Prisoners, persons with decisional incapacity, and any person who are directly involved in the study, including their immediate family members, and anybody who may have any conflict of interest such as employees of ERBE, USA.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Submucosal Endoscopic Mucosal Flap Technique
|
Submucosal Endoscopy with Mucosal Flap (SEMF) technique involves the following: (1) injecting 0.9 % normal saline solution to create a submucosal cushion, (2) tiny cut is made into the cushion, (3) Balloon will be used to dilate the opening and allow passage of endoscope in the submucosal space, (4) Upon direct visualization of the muscle fibers, the doctor will cut the circular layers of the diseased muscles, and (5) Tiny clips will be used to close the tiny cut made earlier.
Other Names:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Lower esophageal sphincter pressure (LES)
Time Frame: at 3 months post endoscopic myotomy
|
High Resolution Esophageal Manometry will be done at 3 months to measure LES and the result will be compared to baseline or pre-endoscopic myotomy LES pressure.
|
at 3 months post endoscopic myotomy
|
Change in frequency of dysphagia
Time Frame: 4 weeks post procedure
|
Swallowing difficulty (dysphagia) will be assessed using the Modified Eckhardt Dysphagia Assessment Tool which includes asking the patient how often he/she experiences swallowing difficulty (0 = none, 1 = occasional, 2 = daily, and 3 = every meal.
The score will be compared to pre-myotomy score.
|
4 weeks post procedure
|
Change in frequency of Regurgitation
Time Frame: 4 weeks post procedure
|
Patient will be asked how often he/she brings up swallowed liquid/solid food or regurgitates (0 = none, 1 = occasional, 2 = daily, and 3 = every meal.
The score will be compared to the score prior to the procedure.
|
4 weeks post procedure
|
Change in frequency of chest pain
Time Frame: 4 weeks post procedure
|
The patient will be asked how often he/she experiences chest pain and the frequency (0 = none, 1 = occasional, 2 = daily, and 3 = every meal.
The score will be compared to pre-myotomy score.
|
4 weeks post procedure
|
Presence of perforation
Time Frame: During endoscopic myotomy procedure
|
Presence of perforation that is seen during the endoscopic procedure.
|
During endoscopic myotomy procedure
|
Presence of bleeding
Time Frame: During endoscopic myotomy procedure
|
Occurence of bleeding during the procedure.
|
During endoscopic myotomy procedure
|
Presence of mediastinal emphysema
Time Frame: During endoscopic myotomy procedure
|
Presence of mediastinal emphysema will be recorded.
|
During endoscopic myotomy procedure
|
Presence of Infection
Time Frame: 4 weeks post procedure
|
Presence of infection within the first 4 weeks post myotomy will be recorded.
|
4 weeks post procedure
|
Development of stricture at the myotomy site.
Time Frame: 3 months post procedure
|
Development of stricture will be assessed by performing an upper endoscopy for patients with change in their Modified Dysphagia Score.
|
3 months post procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence and frequency of heartburn
Time Frame: 4 weeks post procedure
|
The patient will be asked for presence or absence of heartburn.
If present, he/she will be asked for frequency (0 = none, 1 = occasional, 2 = daily, and 3 = every meal).
The score will be compared to pre-myotomy score.
|
4 weeks post procedure
|
Frequency of use of antacids (PPI, H-2 antagonists)
Time Frame: 4 weeks post procedure
|
The patient will be asked if he/she is using any type of antacid.
If using antacid, he/she will be asked how often he/she is using it (0 = none, 1 = occasional, 2 = daily, and 3 = every meal).
The score will be compared to pre-myotomy score.
|
4 weeks post procedure
|
Change in patient's weight
Time Frame: At 3, 6, 9, and 12 months post procedure.
|
Post myotomy weight will be measured and recorded and compared to pre-myotomy weight.
|
At 3, 6, 9, and 12 months post procedure.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Stavros N Stavropoulos, MD, Winthrop University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10035
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dysphagia
-
Morinaga Milk Industry Co., LTDHospital de MataróRecruitingDysphagia | Swallowing Disorder | Dysphagia, Oral Phase | Dysphagia, Esophageal | Dysphagia, OropharyngealSpain
-
All India Institute of Medical Sciences, New DelhiRecruitingOropharyngeal Dysphagia | Dysphagia, Late Effect of Stroke | Transfer Dysphagia | Cricopharyngeus Muscle DysfunctionIndia
-
National Taiwan University HospitalRecruitingDysphagia, Swallowing Function, Diet Modification, Dysphagia Diet, Diet StandardizationTaiwan
-
University of Southern CaliforniaRecruitingDysphagia | Pharyngeal Dysphagia | Oral Pharyngeal DysphagiaUnited States
-
Peter Belafsky, MDTerminatedDysphagia | Oropharyngeal Dysphagia (OPD)United States
-
Atlantic Health SystemRecruitingPost Extubation DysphagiaUnited States
-
University of California, DavisCalifornia Institute for Regenerative Medicine (CIRM); Cook MyoSiteRecruitingOropharyngeal DysphagiaUnited States
-
University of British ColumbiaB.C. Rehabilitation FoundationCompletedThin Liquid DysphagiaCanada
-
Umm Al-Qura UniversityCompleted
-
NestléCompleted
Clinical Trials on Submucosal endoscopic myotomy with mucosal flap technique
-
Professor Michael BourkeCompletedColonic PolypsAustralia
-
UMC UtrechtComprehensive Cancer Centre The NetherlandsUnknownColorectal NeoplasmsNetherlands
-
State Scientific Centre of Coloproctology, Russian...Active, not recruitingEndoscopic Mucosal Resection With Circumferential IncisionRussian Federation
-
University of British ColumbiaRecruitingColon Adenoma | Colon Polyp | Colon LesionCanada
-
Baylor College of MedicineNot yet recruitingEsophageal Neoplasm | Endoscopic Submucosal Dissection | Esophageal Polyp | Bipolar ElectocauteryUnited States
-
Fudan UniversityUnknown
-
Western Sydney Local Health DistrictRecruitingColorectal Neoplasm | Endoscopic Mucosal ResectionAustralia
-
Baylor College of MedicineActive, not recruiting
-
Universitätsklinikum Hamburg-EppendorfTerminatedColorectal Adenomatous Polyp | Colorectal Adenoma With Mild Dysplasia | Colorectal Adenoma With Severe Dysplasia | Colorectal Low Grade Intraepithelial Neoplasia | Colorectal High Grade Intraepithelial NeoplasiaGermany, United Kingdom
-
Professor Michael BourkeWithdrawn